Le-blen Egf Serum
Product Images NDC 72271-100

2 FDA label images from Leblen Beauty Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Le-blen Egf Serum (NDC 72271-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leblen Beauty Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6aa08fa7 E8e4 7625 E053 2a91aa0ab6fb

6aa08fa7 E8e4 7625 E053 2a91aa0ab6fb
Drug Facts panel for Le-Blen EGF Serum outlining active ingredients with their concentrations and skin protectant purpose, uses for skin care after laser treatments and addressing wrinkles, pores, sunburn, dry skin, and dark spots. Includes warnings for external use only, specific precautions when skin is irritated, directions for application, storage advice, and a list of inactive ingredients. Distributed by Le-Blen Beauty Inc, made in the USA.*
FDA Label Image

Le-blen Egf Serum (Efg Dfp)

Le-blen Egf Serum (Efg Dfp)
Drug Facts panel for Le-Blen EGF Serum detailing active ingredients glycerin (25%), SH-oligopeptide-1 (0.95%), and sodium hyaluronate (0.7%) as skin protectants. The panel includes uses, warnings, directions, other information, inactive ingredients, and distributor information from Le-Blen Beauty Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.